Background: To assess the usefulness of commutable secondary reference materials with International Federation of Clinical Chemistry (IFCC)-assigned values, for improving the quality of hemoglobin A1c (HbA 1c ) determination.
The American Diabetes Association (ADA) guidelines (2010) recommend the use of glycosylated hemoglobin (hemoglobin A1c [HbA 1c ]) levels for screening and diagnosis of diabetes. 1 Thus, accuracy in measurement of HbA 1c levels is important for optimal management of diabetes. [2] [3] [4] In recent years, international standardization organizations such as the National 
Materials and Methods

Investigated Equipment
We studied a total of 41 POCT HbA 1c devices from different laboratories in this work of research. Of these, 13 POCT devices were from tertiary hospitals, 17 from secondary hospitals, and 11 from primary hospitals. 
Patient Specimens With Assigned Values
Specimens with IFCC-assigned target values are not suitable for POCT devices. As part of this study, we collected 5-level fresh ethylenediamineteraacetic acid (EDTA) anticoagulated specimens from 5 volunteers who underwent tests to rule out anemia, hemolytic disease, abnormal red blood cell survival cycle, kidney disease, jaundice, and hyperlipidemia. We processed the specimens, which we transported and stored at 2 C to 8 C, for evaluation of the aforementioned POCT 
Evaluation of the Accuracy of 3 POCT Devices
We conducted 3 experiments with the NycoCard, Afinion, and DCA Vantage POCT devices. In experiment 1, specimens with assigned values were tested in duplicate on every POCT device by operators, to obtain a pretraining baseline. In experiment 2, we repeated the same procedure as in experiment 1, after internal calibration with the manufacturer-supplied calibrators.
In experiment 3, we repeated the experiment 1 procedure after the standardized on-site training of personnel.
Because the specimens with IFCC-assigned values are not suitable for testing with POCT devices, we believe that external calibration equation is an appropriate alternative for standardization of POCT devices. The patient specimens were tested on POCT devices and on the central laboratory analyzers; then, we compared the results. In the event of a good linear fit, a mathematical fit was established (Y ¼ aX þ b, where Y refers to the POCT results, and X refers to the central lab results); and then a certain Y value was obtained (ie, calibrated POCT result). POCT devices and those obtained with the central laboratory analyzers. Table 2 shows that the linear fits were established between the POCT devices and the central laboratory analyzers, and a linear fitting formula was obtained. After establishing the fit, r 2 was greater than 0.95. The data pertaining to Alere Afinion devices are not included in Table 2 because the number of these devices was less than 10. We calculated POCT results using these equations and, again, obtained a linear fit. This investigation showed that the precalibration mean bias for fresh patient specimens 1 to 5 was 5 mmol per mol (0.5%), 1 mmol per mol (0.1%), 12 mmol per mol (1.1%), 7 mmol per mol (0.6%) and 1 mmol per mol (0.1%), respectively. This bias was reduced to 0 mmol per mol (0%), 0 mmol per mol (0%), 1 mmol per mol (0.1%), 1 mmol per mol (0.1%), and 0 mmol per mol (0%), respectively, after calibration. The linear relationship of the POCT results and the assigned values improved significantly by external mathematical calibration of the 41 total POCT devices ( Figure 1A) , with a significant reduction in bias to less than 5% SD ( Figure 1B) .
Statistical Analysis
The interlaboratory imprecision (coefficients of variation
[CVs]) for HbA 1c determination by POCT devices was reduced significantly after standardized on-site training of operators. For instance, the CVs in the NycoCard group decreased from 12% to 4%. The CVs in the DCA Vantage group also were reduced after training; however, the change in this value was less dramatic compared with that observed in the NycoCard group. The CVs in the Afinion group showed a similar trend as that observed in the DCA Vantage group. However, in all 3 POCT groups, there was no significant improvement with respect to CVs after the manufacturer-provided internal calibration. Also, the change in CVs after implementing this internal calibration showed variable results: CVs for specimens 1 and 5 declined, but those values for specimens 2 through 4 showed little change ( Figure 2 ).
Discussion
A number of techniques are used for laboratory determination of serum HbA 1c levels. 11 These techniques can be divided into 2 categories based on their assay principles. The first category is based on the electric charge differences of glycated and nonglycated hemoglobin, which are assessed using techniques such as ion exchange chromatography and electrophoresis. The second category is based on the structural characteristics of the glycated hemoglobin, assessed via affinity chromatography and immunoassay. The clinical requirement for the accuracy of HbA 1c determination is less than 0.5% because a change of 0.5% is considered to be clinically significant. 5 The international quality specification for intra-and interlaboratory CVs is less than 2% and less than 3%, respectively. POCT, point-of-care test; CV, coefficient of variation. 14 However, studies have documented a lack of standardization and the existence of considerable method-specific, as well as interlaboratory, variability in this respect. 15 We investigated 3 types of POCT devices from 2 manufacturers, which are used by most clinical laboratories in Beijing. However, the accuracy of HbA 1c POCT instruments has often been contested. 8, 12, 16 In this study, we investigated the clinical laboratories at 41 medical institutions. We attempted to calibrate POCT devices using external mathematical equations and established a linear fitting formula for the POCT results and central laboratory results. A significant reduction in bias was observed for all 5 specimens after calibration.
We also assessed the outcomes of standardized training on the interlaboratory variability in POCT results. For the NycoCard devices, staff training led to a reduction in interlaboratory imprecision. The highest pretraining CV for the 5 specimens was 12%, which decreased to less than 4% for 4 of the 5 specimens and to less than 5% for all specimens.
In conclusion, calibration of laboratory devices using specimens with IFCC-assigned values and by external 
